Your browser doesn't support javascript.
loading
Association of Pulsatility with Gastrointestinal Bleeding in a Cohort of HeartMate II Recipients.
Edwards, Adam L; Fitzmorris, Paul; Pamboukian, Salpy V; George, James F; Wilcox, C Mel; Peter, Shajan.
Afiliação
  • Edwards AL; From the Basil I. Hirschowitz Center of Endoscopic Excellence, Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
  • Fitzmorris P; From the Basil I. Hirschowitz Center of Endoscopic Excellence, Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
  • Pamboukian SV; Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
  • George JF; Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
  • Wilcox CM; From the Basil I. Hirschowitz Center of Endoscopic Excellence, Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
  • Peter S; From the Basil I. Hirschowitz Center of Endoscopic Excellence, Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
ASAIO J ; 64(4): 472-479, 2018.
Article em En | MEDLINE | ID: mdl-29489463
ABSTRACT
Gastrointestinal bleeding (GIB) is common in patients with continuous-flow left ventricular assist devices (CF-LVADs) possibly because of changes in blood flow. We aimed to test the hypothesis that a low pulsatility index (PI) is associated with an increased hazard of overt GIB in patients with CF-LVADs. We conducted a retrospective cohort study of patients who had a HeartMate II (HMII) CF-LVAD implanted at our center. The study end-point was the first overt GIB causing or occurring during a hospitalization between 6 days and 6 months after HMII implantation. HMII PI was recorded at 48 hours and at 1, 3, and 6 month intervals after implantation. We analyzed the associations of PI and clinical variables with the hazard of overt GIB. Ninety-five patients met eligibility criteria. PI ranged from 2.5 to 5.9 (low PI < 4.15 and high PI ≥ 4.15 on the basis of receiver operating characteristic curve analysis). Seventeen (18%) patients experienced overt GIB. In a multivariable model, only lower baseline hemoglobin was a significant predictor of an increased hazard of overt GIB. After adjusting for the baseline hemoglobin, low PI was independently associated with an increased hazard of overt GIB in our cohort of HMII recipients.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coração Auxiliar / Hemorragia Gastrointestinal Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coração Auxiliar / Hemorragia Gastrointestinal Idioma: En Ano de publicação: 2018 Tipo de documento: Article